Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial
Background: Quercetin, a natural polyphenol with demonstrated broad-spectrum antiviral, anti-inflammatory, and antioxidant properties, has been proposed as an adjuvant for early-stage coronavirus disease 2019 (COVID-19) infection.Objective: To explore the possible therapeutic effect of quercetin in...
Saved in:
Main Authors: | Francesco Di Pierro (Author), Amjad Khan (Author), Somia Iqtadar (Author), Sami Ullah Mumtaz (Author), Muhammad Nabeel Akbar Chaudhry (Author), Alexander Bertuccioli (Author), Giuseppe Derosa (Author), Pamela Maffioli (Author), Stefano Togni (Author), Antonella Riva (Author), Pietro Allegrini (Author), Martino Recchia (Author), Nicola Zerbinati (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Berberine Phytosome on reproductive, dermatologic, and metabolic characteristics in women with polycystic ovary syndrome: a controlled, randomized, multi-centric, open-label clinical trial
by: Francesco Di Pierro, et al.
Published: (2023) -
Influence of the microbiota on the effectiveness and toxicity of oncological therapies, with a focus on chemotherapy
by: Massimiliano Cazzaniga, et al.
Published: (2023) -
Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19-Results From a Pilot Open-Label, Randomized Controlled Trial
by: Amjad Khan, et al.
Published: (2022) -
Ertugliflozin: a sodium-glucose cotransporter-2 (SGLT-2) inhibitor for glycemic control in type 2 diabetes
by: Derosa G, et al.
Published: (2018) -
A cosmeceutical formulation based on boswellic acids for the treatment of erythematous eczema and psoriasis
by: Togni S, et al.
Published: (2014)